Literature DB >> 7873955

Events per person year--a dubious concept.

J Windeler1, S Lange.   

Abstract

In 1982 a new measure was introduced in research into osteoporosis and is now used everywhere in the literature. The so called "fracture rate" relates the number of fractures (single in some patients, multiple in others) to the cumulative time of observation of all patients. This concept, however, has no sound basis. Counting events instead of patients usually violates basic statistical assumptions and invalidates the use of common statistical tests and estimators. Its clinical interpretation is rather dubious. The use of such a measure impedes the search for valid and clinically meaningful outcome criteria and should be abandoned.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7873955      PMCID: PMC2548825          DOI: 10.1136/bmj.310.6977.454

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

Review 1.  Intention-to-treat analysis: implications for quantitative and qualitative research.

Authors:  D J Newell
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

2.  T-cell receptors in ataxia-telangiectasia.

Authors: 
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

3.  Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.

Authors:  T Storm; G Thamsborg; T Steiniche; H K Genant; O H Sørensen
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

4.  Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche
Journal:  Control Clin Trials       Date:  1989-03

5.  Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

Authors:  N B Watts; S T Harris; H K Genant; R D Wasnich; P D Miller; R D Jackson; A A Licata; P Ross; G C Woodson; M J Yanover
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

6.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

7.  Effect of calcitonin and vitamin D in osteoporosis.

Authors:  G M Palmieri; J A Pitcock; P Brown; J G Karas; L J Roen
Journal:  Calcif Tissue Int       Date:  1989-09       Impact factor: 4.333

8.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

9.  Fracture thresholds in osteoporosis: implications for hormone replacement treatment.

Authors:  P J Ryan; G M Blake; I Fogelman
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  19 in total

1.  Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.

Authors:  J McCormack; T Greenhalgh
Journal:  BMJ       Date:  2000-06-24

2.  Evaluation of benefit-risk.

Authors:  Silvio Garattini
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial.

Authors:  Lutz Heinemann; Norbert Hermanns
Journal:  J Diabetes Sci Technol       Date:  2015-08-06

4.  Events per person year. Can obscure the true risk of certain adverse drug reactions.

Authors:  K R Paterson
Journal:  BMJ       Date:  1995-06-03

5.  Events per person year. Use individual event rate adjustment for follow up time.

Authors:  E Löyttyniemi; K Laitinen; J Tuominen
Journal:  BMJ       Date:  1995-06-03

6.  Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.

Authors:  A Siebenhofer; J Plank; A Berghold; K Horvath; P T Sawicki; P Beck; T R Pieber
Journal:  Diabetologia       Date:  2004-11-25       Impact factor: 10.122

7.  A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors.

Authors:  Y Yazici; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

Review 8.  Hip fracture prevention: cost-effective strategies.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

9.  Events per person year. A decrease in multiple events may be missed.

Authors:  J A Kanis; E V McCloskey
Journal:  BMJ       Date:  1995-06-03

Review 10.  Ways of measuring rates of recurrent events.

Authors:  R J Glynn; J E Buring
Journal:  BMJ       Date:  1996-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.